The AMPA receptor/Na(+) channel blocker BIIR 561 CL is protective in a model of global cerebral ischaemia

In this study, we investigated whether the novel neuroprotective compound dimethyl-[2-[2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-phenoxy]-ethyl]-amine hydrochloride, BIIR 561 CL, a combined non-competitive antagonist of AMPA receptors and blocker of voltage-gated Na+ channels, is protective in a rat model of severe global ischaemia. BIIR 561 CL administered immediately after 10 min of ischaemia (occlusion of both carotid arteries plus reduction of arterial blood pressure to 38-40 mm Hg) significantly reduced hippocampal damage at 4 x 26.8 mg/kg (subcutaneous injections). The competitive AMPA receptor antagonist 2,3-dihydro-6-nitro-7-sulfamoyl-benz(F)quinoxaline, NBQX, was used as a reference compound and was protective at 3x30 mg/kg (intraperitoneal and/or subcutaneous administration). BIIR 561 CL significantly reduced the ischaemia-induced premature mortality from 33.6% in the controls to 14.3%, whereas NBQX treatment had no statistically significant effect.Thus, BIIR 561 CL could be shown to reduce hippocampal damage and premature mortality in a model of severe global ischaemia. A compound with these properties might be an interesting candidate for the treatment of disorders related to global cerebral ischaemia in man.

Mechanocardiographic assessment of systolic time intervals in normal children

Systolic time intervals (STI) were measured in 469 normal children, aged 5.0 to 16.9 years, using simultaneous recordings of the electrocardiogram, phonocardiogram and an external carotid pulse tracing. The data were analyzed to define the influence of sex, age, cardiac cycle length, body weight (BW), body length (BL), and body surface area (BSA) on the left ventricular STI. Regression, equations were evaluated for the calculation of normal standards for the following STI: electromechanical systole (QS2), left ventricular ejection time (LVET), pre-ejection period (PEP) systolic quotient (PEP/LVET), isovolumic contraction time (IVCT), electroacustical delay (QS1), and additionally for the so-called tension time (TT), upstroke time (UT), and the ascending index (UT/LVET) of the carotid pulse wave. Heart rate was found to influence all of the STI but the ratio UT/LVET, which revealed to be independent of any variable. Besides heart rate, BSA proved to be a second relevant independent variable for QS2 and LVET, respectively BL for PEP, PEP/LVET and QS1. These findings are in accordance to the results of comparable echocardiographic studies but disagree previous mechanocardiographic studies in smaller groups of children in whom age and not the above-mentioned parameters of the individual development seemed to influence the STI. A second set of equations was evaluated for the calculation of 95%-prediction intervals for the particular STI permitting to define abnormalities of the STI in individual children.